Partner T.J. Ferrante was quoted in a Modern Healthcare article, “After Livongo win, pressure is on 7wireVentures’ second fund,” about whether the digital health venture capital firm can deliver another slam dunk akin to its early investment in Livongo, which exited to the tune of $18.5 billion.
Ferrante said 7wire provides startups with connections. And its pool of strategic investors – who collectively touch up to 30 million lives in the U.S. – gives 7wire a competitive advantage over other venture capital firms. Leverage in the venture capital world has shifted to company founders, who have a lot of choices when it comes to shopping for their next funding round, he said.
“If your business model is to get into networks with health plans, even if you have money, it’s still a very bureaucratic process,” he said. “If you have an inside track to that, it’s extremely appealing to get in that space.”